# Champions Oncology, Inc.: filings

CSBR · Nasdaq · CIK 771856 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/csbr.md) · [Financials](/companies/csbr/financials.md) · [Filings](/companies/csbr/filings.md) · [Insiders](/companies/csbr/insiders.md)

## Reports and events: 248 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 196, 8-K 138, 10-Q 53, 3 24, 10-K 18, DEF 14A 15, UPLOAD 15, SC 13D/A 10, CORRESP 9, D 8, DEFA14A 8, SC 13D 6, 10-Q/A 3, EFFECT 3, SC 13G 3, SC 13G/A 3, 10-K/A 2, 424B3 2, CT ORDER 2, DEF 14C 2, DEFR14A 2, PRE 14C 2, PRER14C 2, S-1 2, S-8 2, 424B4 1, 4/A 1, 8-A12B 1, CERTNAS 1, DEFC14A 1, DEFM14A 1, NT 10-K 1, POS AM 1, PRE 14A 1, PRER14A 1, S-1/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 16:15 ET | [8-K](/filings/0001628280-26-066087.md) | 5.07 Shareholder vote results | 0001628280-26-066087 |
| 2026-09-11 | 18:51 ET | [10-Q](/filings/0001628280-26-061519.md) | Quarterly report, period 2026-07-31 | 0001628280-26-061519 |
| 2026-09-10 | 20:46 ET | [8-K](/filings/0001628280-26-061383.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-061383 |
| 2026-08-28 | 19:35 ET | [DEF 14A](/filings/0001628280-26-059373.md) | Proxy statement, period 2026-08-27 | 0001628280-26-059373 |
| 2026-07-27 | 20:45 ET | [10-K](/filings/0001628280-26-049834.md) | Annual report, period 2026-04-30 | 0001628280-26-049834 |
| 2026-07-27 | 20:31 ET | [8-K](/filings/0001628280-26-049822.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049822 |
| 2026-03-30 | 17:16 ET | [8-K](/filings/0001628280-26-021941.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-021941 |
| 2026-03-12 | 20:56 ET | [10-Q](/filings/0001628280-26-017345.md) | Quarterly report, period 2026-01-31 | 0001628280-26-017345 |
| 2026-03-12 | 20:17 ET | [8-K](/filings/0001628280-26-017259.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-017259 |
| 2025-12-15 | 21:59 ET | [10-Q](/filings/0001628280-25-057082.md) | Quarterly report, period 2025-10-31 | 0001628280-25-057082 |
| 2025-12-15 | 21:14 ET | [8-K](/filings/0001628280-25-057020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-057020 |
| 2025-10-16 | 21:05 ET | [8-K](/filings/0001628280-25-045241.md) | 5.07 Shareholder vote results | 0001628280-25-045241 |
| 2025-09-15 | 20:50 ET | [10-Q](/filings/0000771856-25-000023.md) | Quarterly report, period 2025-07-31 | 0000771856-25-000023 |
| 2025-09-15 | 20:47 ET | [8-K](/filings/0000771856-25-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000771856-25-000022 |
| 2025-08-22 | 19:20 ET | [DEF 14A](/filings/0000771856-25-000009.md) | Proxy statement, period 2025-08-22 | 0000771856-25-000009 |
| 2025-07-23 | 21:01 ET | [10-K](/filings/0001628280-25-035765.md) | Annual report, period 2025-04-30 | 0001628280-25-035765 |
| 2025-07-23 | 20:11 ET | [8-K](/filings/0001628280-25-035727.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-035727 |
| 2025-07-21 | 17:49 ET | [8-K](/filings/0001628280-25-035424.md) | 9.01 Financial statements and exhibits | 0001628280-25-035424 |
| 2025-03-17 | 15:03 ET | [10-Q](/filings/0001628280-25-012941.md) | Quarterly report, period 2025-01-31 | 0001628280-25-012941 |
| 2025-03-11 | 20:32 ET | [8-K](/filings/0001628280-25-012022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-012022 |
| 2024-12-16 | 21:16 ET | [10-Q](/filings/0001628280-24-051389.md) | Quarterly report, period 2024-10-31 | 0001628280-24-051389 |
| 2024-12-11 | 21:40 ET | [8-K](/filings/0001628280-24-050789.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-050789 |
| 2024-10-15 | 13:43 ET | [8-K](/filings/0001628280-24-042780.md) | 5.07 Shareholder vote results | 0001628280-24-042780 |
| 2024-10-03 | 15:12 ET | [8-K](/filings/0001628280-24-042039.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-042039 |
| 2024-09-13 | 17:07 ET | [10-Q](/filings/0001628280-24-040312.md) | Quarterly report, period 2024-07-31 | 0001628280-24-040312 |
| 2024-09-11 | 20:34 ET | [8-K](/filings/0001628280-24-040137.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-040137 |
| 2024-08-27 | 20:34 ET | [DEF 14A](/filings/0001628280-24-038540.md) | Proxy statement, period 2024-08-27 | 0001628280-24-038540 |
| 2024-07-19 | 20:29 ET | [10-K](/filings/0001628280-24-032321.md) | Annual report, period 2024-04-30 | 0001628280-24-032321 |
| 2024-07-18 | 20:13 ET | [8-K](/filings/0001628280-24-032227.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-032227 |
| 2024-05-06 | 23:46 ET | [SC 13D/A](/filings/0001072613-24-000427.md) | Ownership report, active investor, amended | 0001072613-24-000427 |
| 2024-03-15 | 21:37 ET | [10-Q](/filings/0001628280-24-011279.md) | Quarterly report, period 2024-01-31 | 0001628280-24-011279 |
| 2024-03-12 | 20:31 ET | [8-K](/filings/0001628280-24-010569.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-010569 |
| 2023-12-13 | 21:47 ET | [10-Q](/filings/0001628280-23-041457.md) | Quarterly report, period 2023-10-31 | 0001628280-23-041457 |
| 2023-12-12 | 21:14 ET | [8-K](/filings/0001628280-23-041308.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-041308 |
| 2023-10-19 | 20:32 ET | [8-K](/filings/0001628280-23-034703.md) | 5.07 Shareholder vote results | 0001628280-23-034703 |
| 2023-10-17 | 12:37 ET | [8-K](/filings/0001628280-23-034475.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-034475 |
| 2023-09-13 | 21:18 ET | [10-Q](/filings/0001628280-23-032212.md) | Quarterly report, period 2023-07-31 | 0001628280-23-032212 |
| 2023-09-13 | 20:00 ET | [8-K](/filings/0001628280-23-032185.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-032185 |
| 2023-08-28 | 19:12 ET | [DEF 14A](/filings/0001628280-23-030752.md) | Proxy statement, period 2023-08-28 | 0001628280-23-030752 |
| 2023-07-24 | 20:17 ET | [10-K](/filings/0001628280-23-025464.md) | Annual report, period 2023-04-30 | 0001628280-23-025464 |
| 2023-07-24 | 20:04 ET | [8-K](/filings/0001628280-23-025452.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-025452 |
| 2023-04-05 | 15:39 ET | [8-K](/filings/0001628280-23-010813.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-010813 |
| 2023-03-16 | 18:03 ET | [10-Q](/filings/0001628280-23-008251.md) | Quarterly report, period 2023-01-31 | 0001628280-23-008251 |
| 2023-03-15 | 19:59 ET | [8-K](/filings/0001628280-23-008080.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-008080 |
| 2022-12-13 | 21:32 ET | [10-Q](/filings/0001628280-22-031818.md) | Quarterly report, period 2022-10-31 | 0001628280-22-031818 |
| 2022-12-13 | 21:01 ET | [8-K](/filings/0001628280-22-031796.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-031796 |
| 2022-10-20 | 15:21 ET | [8-K](/filings/0001628280-22-026738.md) | 5.07 Shareholder vote results | 0001628280-22-026738 |
| 2022-09-12 | 20:52 ET | [10-Q](/filings/0001628280-22-024751.md) | Quarterly report, period 2022-07-31 | 0001628280-22-024751 |
| 2022-09-08 | 19:59 ET | [8-K](/filings/0001628280-22-024587.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-024587 |
| 2022-08-31 | 13:29 ET | [DEF 14A](/filings/0001628280-22-023938.md) | Proxy statement, period 2022-08-29 | 0001628280-22-023938 |

Page 1 of 5. [Older](/companies/csbr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. No prices; not investment advice.